Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses

Buruli ulcer (BU), caused by Mycobacterium ulcerans, is currently treated with a daily combination of rifampin and either injectable streptomycin or oral clarithromycin. An intermittent oral regimen would facilitate treatment supervision. We first evaluated the bactericidal activity of newer antimic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauffour, Aurélie, Robert, Jérôme, Veziris, Nicolas, Aubry, Alexandra, Pethe, Kevin, Jarlier, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494103/
https://www.ncbi.nlm.nih.gov/pubmed/32866170
http://dx.doi.org/10.1371/journal.pntd.0007857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494103/
https://www.ncbi.nlm.nih.gov/pubmed/32866170
http://dx.doi.org/10.1371/journal.pntd.0007857

Ejemplares similares